A Study of Haploidentical Bone Marrow Transplant for Patients With Hematologic Malignancies
Status:
Suspended
Trial end date:
2021-07-01
Target enrollment:
Participant gender:
Summary
The primary objective is to determine overall survival 180 days after transplantation
involving HLA-haploidentical stem cell/bone marrow graft, and post-transplant Cy.